ARCA biopharma (NASDAQ:ABIO) Now Covered by StockNews.com
StockNews.com began coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a research note published on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Price Performance ABIO stock opened at $2.40 on Friday. The stock has a market capitalization of $34.82 million, a P/E ratio of -5.71 […]
More Stories
Camping World (NYSE:CWH) Price Target Raised to $28.00
Camping World (NYSE:CWH – Free Report) had its price target hoisted by Truist Financial from $26.00 to $28.00 in a...
Consolidated Edison (NYSE:ED) Price Target Raised to $106.00 at UBS Group
Consolidated Edison (NYSE:ED – Free Report) had its price objective boosted by UBS Group from $105.00 to $106.00 in a...
Marcus’ (MCS) “Outperform” Rating Reaffirmed at Barrington Research
Barrington Research reissued their outperform rating on shares of Marcus (NYSE:MCS – Free Report) in a research note published on...
Analysts Set Canoo Inc. (NASDAQ:GOEV) PT at $23.04
Canoo Inc. (NASDAQ:GOEV – Get Free Report) has earned a consensus rating of “Moderate Buy” from the seven analysts that...
Heritage Financial Co. (NASDAQ:HFWA) Receives $23.50 Consensus Target Price from Analysts
Heritage Financial Co. (NASDAQ:HFWA – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the four...
Truist Financial Boosts Darden Restaurants (NYSE:DRI) Price Target to $195.00
Darden Restaurants (NYSE:DRI – Free Report) had its price objective hoisted by Truist Financial from $185.00 to $195.00 in a...